| scholarly article | Q13442814 |
| P2093 | author name string | Hahn D | |
| Cooper PA | |||
| Driessen M | |||
| Ellis JB | |||
| Wainer S | |||
| De Villiers FP | |||
| Muwazi F | |||
| Gous H | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| septicemia | Q1110041 | ||
| fluconazole | Q411478 | ||
| amphotericin B | Q412223 | ||
| P304 | page(s) | 1107-1112 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | Pediatric Infectious Disease Journal | Q15756717 |
| P1476 | title | Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial | |
| P478 | volume | 15 |
| Q33680336 | Administration of fluconazole in children below 1 year of age. |
| Q27022585 | Advances in the treatment of invasive neonatal candidiasis |
| Q37854727 | Amphotericin B use in children: conventional and lipid-based formulations |
| Q36967212 | Antifungal agents in neonates: issues and recommendations. |
| Q35588487 | Antifungal pharmacotherapy for neonatal candidiasis |
| Q35897495 | Antifungal therapy and outcomes in infants with invasive Candida infections |
| Q24202811 | Antifungal therapy for newborn infants with invasive fungal infection |
| Q24239978 | Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections |
| Q35752870 | Antifungals in systemic neonatal candidiasis |
| Q43893250 | Antimicrobial drugs encapsulated in fibrin nanoparticles for treating microbial infested wounds |
| Q44800587 | Candida infections in newborns |
| Q30792309 | Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. |
| Q34505582 | Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America |
| Q30433993 | Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants |
| Q36968140 | Clinical pharmacology of antifungal agents in pediatric patients |
| Q34936576 | Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. |
| Q38284461 | Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. |
| Q61757070 | Diagnose und Therapie der Sepsis |
| Q44754456 | Diagnosis and therapy of sepsis |
| Q46406734 | External Evaluation of Two Fluconazole Infant Population Pharmacokinetic Models |
| Q34490092 | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? |
| Q43696321 | Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis |
| Q38263282 | Invasive candidiasis and candidaemia in neonates and children: update on current guidelines |
| Q37973390 | Invasive fungal infections during the neonatal period: diagnosis, treatment and prophylaxis |
| Q38119554 | Invasive fungal infections in newborns and current management strategies |
| Q37682908 | Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy |
| Q34680771 | Management of neonatal candidiasis. Neonatal Candidiasis Study Group |
| Q35296941 | Neonatal pneumonia in developing countries |
| Q35040309 | Perinatal infections and brain injury: current treatment options |
| Q38215682 | Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants. |
| Q27025299 | Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications |
| Q24247738 | Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants |
| Q38074608 | Safety of fluconazole in paediatrics: a systematic review |
| Q24247376 | Systemic antifungal drugs for invasive fungal infection in preterm infants |
| Q27001567 | Treatment and prophylaxis of invasive candidiasis |
| Q38056762 | Treatment of invasive candidiasis in neutropenic patients: systematic review of randomized controlled treatment trials |
| Q37777197 | Update on antifungal agents for paediatric patients |
| Q37374850 | Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007. |
Search more.